None listed
Conditions
Interventions
Intervention1: Shveta Labs Face Serum with Ghee and Rose: Apply 2 3 drops of the serum uniformly to the face and neck once daily after cleansing, and gently massage until absorbed.
Control Interventio
Sponsors
Shveta Labs
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and Female trial participants aged between 35 to 55 years both ages inclusive. 2. Participants presenting with fine lines with a score of greater or equal to 4 and wrinkles with a score of greater or equal to2, as assessed by the investigator using a validated grading scale. 3. Trial participants with facial oiliness scores between 4 and 6, as determined by the investigator. 4. Trial participants presenting with visible dark spots, acne marks, or facial hyperpigmentation. 5. Trial participants free of excessive hair, cuts, abrasions, fissures, wounds, lacerations, tattoos or any other skin conditions on their face. 6. Trial participants willing to give a voluntary written informed consent and agree to come for regular follow-up. 7. Trial participants willing to abide by and comply with the study protocol.
Exclusion criteria
Exclusion criteria: 1. Female trial participants who are pregnant or nursing or have plans of becoming pregnant during the study self-declared. 2. Trial participants taking part in another study liable to interfere with this study. 3. Trial participants with known history or present condition of an allergic response to any cosmetic product. 4. Trial participants with any other signs of significant skin irritation or skin disease or currently taking any medication, which the Investigator believes may influence the interpretation of the data. 5. Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Change from baseline to Weeks 2, 4, and 8 in dermatologist-assessed overall skin condition, including skin hydration, sebum levels, skin brightness, fine lines, wrinkles, and pigmentation scores. 2.Change from baseline to Weeks 2, 4, and 8 in skin brightness and pigmentation parameters measured by spectrophotometer. 3.Change from baseline to Weeks 2, 4, and 8 in Antera 3D-derived parameters for fine lines, wrinkles, and pigmentation. 4.Change from baseline to Weeks 2, 4, and 8 in skin hydration values measured by Corneometer. 5.Change from baseline to Weeks 2, 4, and 8 in TEWL values measured by Tewameter. Change from baseline to Weeks 2, 4, and 8 in sebum levels measured by Sebumeter.Timepoint: D1, D15, D29, D57 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Change from baseline to Weeks 2, 4, and 8 in overall skin appearance parameters, including skin texture, spots, and wrinkles, as assessed by VISIA imaging analysis. 2.Change in subject self-assessment scores for hydration, smoothness, brightness, oil control, and overall skin improvement over the study period. 3.Incidence, severity, and relationship of adverse events throughout the study; dermatological tolerability assessment scores at each visit Timepoint: D1, D15, D29, D57 | — |
Countries
India
Contacts
Public ContactSudhanthiran S
MS Clinical Research Pvt. Ltd
Outcome results
None listed